February 2026
1. AHMAD MM, Gulzar MW, Azeem MW, Mubashar MM, et al
   Molecular Detection and Phylogenetic Characterization of Avian Infectious Bronchitis Virus (IBV) in Vaccinated Commercial Chicken Flocks Experiencing Outbreaks in Faisalabad, Pakistan.
   Arch Virol. 2026;171:73.
   

   >> Share

   
   January 2026
2. ZHANG J, Sun X, Koro C, Fang Y, et al
   Prevalence of group A rotavirus G and P genotypes in children with acute gastroenteritis in China from 2020 to 2021.
   Arch Virol. 2026;171:47.
   

   >> Share

   
   
3. DE OLIVEIRA BARBOSA A, Gava D, Bastos APA, de Lima M, et al
   Immunogenicity of an inactivated vaccine against senecavirus a and duration of the immune response in pigs.
   Arch Virol. 2026;171:33.
   

   >> Share

   
   December 2025
4. CHAI Y, Hu Z
   Adaptive immune response of poultry to Newcastle disease vaccines.
   Arch Virol. 2025;171:14.
   

   >> Share

   
   
5. JAMOUR P, Babaeimarzangou SS, Daneshvar Hosseini N, Gholizadeh Gigloo M, et al
   Immunogenetic insights into matching bivalent inactivated Payavax G79(R) for sustainable poultry vaccination against NDV-GVII and H9N2.
   Arch Virol. 2025;171:13.
   

   >> Share

   
   November 2025
6. LATEEF MO, Aransi AT, Nathaniel D
   Genome diversity and evolutionary understanding of Lassa virus: a holistic approach highlighting a potential target for cross-lineage vaccine development.
   Arch Virol. 2025;171:7.
   

   >> Share

   
   
7. HUSSEIN NA, Azouz RAM, El-Shenawy R, Helmy NM, et al
   A virus-like-particle-producing DNA vaccine triggers specific humoral immunity against hepatitis C virus in mice.
   Arch Virol. 2025;170:244.
   

   >> Share

   
   October 2025
8. RYU NG, Yang YJ, Kim KI
   Application of a multi-epitope DNA vaccine against viral hemorrhagic septicemia virus type ?a.
   Arch Virol. 2025;170:222.
   

   >> Share

   
   September 2025
9. CUI X, Wang S, Han Q, Jin N, et al
   Molecular characterization of infectious laryngotracheitis virus in China and host transcriptomic responses to immunization with a live attenuated vaccine.
   Arch Virol. 2025;170:216.
   

   >> Share

   
   August 2025
10. ZADEH MEHRIZI T, Eshrati B, Ebrahimi Shahmabadi H
    Evaluation of recent pre-booster studies on hepatitis B vaccine effectiveness across WHO regions with HBV prevalence above 1% in the general population up to 60 years of age: a systematic review.
    Arch Virol. 2025;170:193.
    

    >> Share

    
    July 2025
11. NEMOTO M, Kawanishi N, Kambayashi Y, Bannai H, et al
    Growth properties of recombinant equine influenza viruses with different backbones generated by reverse genetics in embryonated chicken eggs.
    Arch Virol. 2025;170:181.
    

    >> Share

    
    June 2025
12. MULONDO G, Buyse MLR, Labuschagne K, Jarvis D, et al
    Production and immunogenicity of a plant-produced beak and feather disease virus vaccine in Japanese quails.
    Arch Virol. 2025;170:163.
    

    >> Share

    
    May 2025
13. CHEN T, Xu W, Duan P, Jiang S, et al
    MF59-like adjuvant containing yeast-derived squalene enhances the humoral immune response to cell-derived influenza vaccine.
    Arch Virol. 2025;170:134.
    

    >> Share

    
    March 2025
14. YE QY, Jiang ZT, Jiang Y, Cai JW, et al
    Effectiveness of inactivated COVID-19 vaccine against symptom severity in hospitalized COVID-19 patients infected with the Omicron variant.
    Arch Virol. 2025;170:88.
    

    >> Share

    
    February 2025
15. KOTHARI D, Patel N, Bishoyi AK
    Dengue: epidemiology, diagnosis methods, treatment options, and prevention strategies.
    Arch Virol. 2025;170:48.
    

    >> Share

    
    January 2025
16. ASHRAF MA, Raza MA, Imran A, Amjad MN, et al
    Next-generation vaccines for influenza B virus: advancements and challenges.
    Arch Virol. 2025;170:25.
    

    >> Share

    
    December 2024
17. SORDO-PUGA Y, Santana-Rodriguez E, Perez-Perez D, Mendez-Orta MK, et al
    Porvac((R)) subunit vaccine induces neutralizing antibodies against all three main classical swine fever virus genotypes.
    Arch Virol. 2024;170:22.
    

    >> Share

    
    
18. OLORUNTIMEHIN ES, Volodina SI, Patraman IV, Nadtochey GA, et al
    Molecular and ultrastructural characteristics of virulent and attenuated vaccine strains of goose parvovirus LIV-22.
    Arch Virol. 2024;170:4.
    

    >> Share

    
    July 2024
19. LIU C, Li S, Qiao M, Zeng C, et al
    GB and gH/gL fusion machinery: a promising target for vaccines to prevent Epstein-Barr virus infection.
    Arch Virol. 2024;169:167.
    

    >> Share

    
    
20. LUO J, Zhang M, Ye Q, Gao F, et al
    A synthetic TLR4 agonist significantly increases humoral immune responses and the protective ability of an MDCK-cell-derived inactivated H7N9 vaccine in mice.
    Arch Virol. 2024;169:163.
    

    >> Share

    
    April 2024
21. ALVAREZ-QUINTO R, Grinstead S, Kinard G, Martin R, et al
    Complete genome sequence of vaccinium-associated virus C, a new member of the family Totiviridae from Vaccinium floribundum.
    Arch Virol. 2024;169:86.
    

    >> Share

    
    March 2024
22. LATIFI T, Kachooei A, Jalilvand S, Zafarian S, et al
    Correlates of immune protection against human rotaviruses: natural infection and vaccination.
    Arch Virol. 2024;169:72.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share